Ligand-protein studies for development of inhibitors of S100P, as a potential novel therapy for pancreatic cancer

Project: Other

Project Details


Our Therapy Accelerator is driving a research collaboration between the University of Cambridge and the University of Hertfordshire to prevent the spread of a lethal form of pancreatic cancer.
Effective start/end date1/04/1831/12/19


  • RC0254 Neoplasms. Tumors. Oncology (including Cancer)
  • Pancreatic Cancer
  • QD Chemistry
  • Biochemistry
  • Drug Discovery
  • QH301 Biology
  • Biochemistry
  • Biophysics


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.